Bleomycin inhibits CLEC14A to attenuate the progression of extracranial arteriovenous malformations

Bleomycin inhibits CLEC14A to attenuate the progression of extracranial arteriovenous malformations

Background: We previously reported that interstitial injection of bleomycin (BLM) reduces the size of early-stage extracranial arteriovenous malformation (AVM). Here, we sought to investigate the potential mechanism of BLM in treating extracranial AVM. Methods: Samples of human extracranial AVM (n=3...

Full description

Bibliographic Details
Main Authors: Congzhen Qiao, Yajing Qiu, Yun Zou, Chen Hua, Yuanbo Li, Yunbo Jin, Xiaoxi Lin
Format: Article
Language:English
Published: KeAi Communications Co. Ltd. 2021-12-01
Series:Chinese Journal of Plastic and Reconstructive Surgery
Subjects:
Bleomycin
Extracranial arteriovenous malformation
CLEC14A
RNA-Sequencing
Online Access:http://www.sciencedirect.com/science/article/pii/S2096691121001102

Similar Items

Similar Items